Search Results 101-110 of 17186 for Nitric oxide

  1. Diazoxide (oral route) - Mayo Clinic

    Description. Diazoxide is used to manage symptoms of hypoglycemia (low blood sugar) that is caused by pancreas cancer, surgery, or other conditions.

  2. Pulmonary Hypertension Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the safety and efffectiveness of pulsed inhaled nitric oxide (iNO) in subjects at risk for pulmonary hypertension ...

  3. Publications - Reade A. Quinton, M.D. - Mayo Clinic

    ... nitric oxide dysregulation. Kidney Int. 2021 Mar; 99 (3):646-656 Epub 2020 Nov 02. View PubMed; Bois MC, Boire NA, Layman AJ, Aubry MC, Alexander MP, Roden AC ...

  4. Publications - Jeff W. Meeusen, Ph.D. - Mayo Clinic

    Reactivity of Zn-, Cd-, and apo-metallothionein with nitric oxide compounds: in vitro and cellular comparison. Chem Res Toxicol. 2010 Feb 15; 23: (2)422-31 ...

  5. Early Feasibility Study To Evaluate The Safety And Recommended Dose Of The Sarah Nanotechnology System, For Patients With Stage 4 Metastatic Solid Tumors.The Investigational Device Uses Iron Oxide Nanoparticles Together With Non-Ionizing Alternating Magnetic Field To Generate Heat And Destroy Tumors - Mayo Clinic

    The AMF heats up the iron oxide core in the nanoparticles, due to their magnetic properties, which in turn causes the temperature to increase within the tumor(s) ...

  6. Publications - Meng Welliver, M.D., Ph.D. - Mayo Clinic

    Inactivation and degradation of O(6)-alkylguanine-DNA alkyltransferase after reaction with nitric oxide. Cancer Res. 2002 Jun 01; 62(11):3037-43. View ...

  7. Publications - Benjamin F. Gruenbaum, M.D., Ph.D. - Mayo Clinic

    ... Nitric Oxide (iNO) during Intrahospital Transport". Crit Care Res Pract ... Clinical Outcomes of Critically Ill Patients Using Inhaled Nitric Oxide (iNO) during ...

  8. Drugs and Supplements that Start with I - Mayo Clinic

    Nitric oxide (inhalation route) · Inotersen (subcutaneous route) · Inotuzumab ozogamicin (intravenous route). Inpefa. Also known as. Sotagliflozin (oral route).

  9. A Study of Ubenimex in Patients with Pulmonary Arterial Hypertension - Mayo Clinic

    On stable dose of at least one of the following PAH-specific therapies. Endothelin receptor antagonist; An agent acting on the nitric oxide pathway ( ...

  10. Publications - Sean P. Kiley, M.D. - Mayo Clinic

    Impact of low dose inhaled nitric oxide treatment in spontaneously breathing and intubated COVID-19 patients: a retrospective propensity-matched study. Crit ...